Okay one thing I will say for the python class so far is that it's at least structured in a way that if you take the quiz immediately after completing the lab and you have the lab assignment open in another window, you can complete the quiz but running the little programs you've just written.
So this was the assignment:
and the quiz was all "What would this fragment of python code output?":
myVal = ord("&")
if myVal == 38:
print("Milkshake")
This is MUCH better than the C# class where the code fragments were theoretical and the only code we touched was minor editing of click events. Like in this case we're learning the concepts and making a little machine to do the quiz instead of watching someone make a little machine and being asked about the concepts that run it. This feels much more hands-on since there's no fiddle-fucking around with dragging and dropping buttons. If I fuck it up I can *see and fix* what I've fucked up.
And while all of the assignments thus far have been exactly like the C# class in format (lectures by the department head with labs by the department head and quizzes and tests written by the department head) APPARENTLY at some point this professor is going to require that we make a video lesson as part of an exam and that at least requires *some* display of learning beyond "have you figured out that you can view the correct answers before retaking the quizzes an unlimited number of times?".
So I'm cautiously optimistic and also in this class I have completed 20 labs in two weeks whereas in the C# class I think I got through seven labs before I gave up because they had no impact on whether I was passing the class or understanding the material. (I have eight more to get through by tomorrow; week one was 17 labs. This feels a lot more like I'm getting things done.)
258 notes
·
View notes
Key Players in the TAVR Market: A Comparative Analysis
The transcatheter Aortic Valve Replacement (TAVR) market has several key players who are at the forefront of developing and supplying TAVR devices. It's important to note that the landscape may evolve, and new players may emerge.
Here is a comparative analysis of some notable key players in the TAVR market:
1. Edwards Lifesciences Corporation:
Overview: A leading player in the TAVR market, Edwards Lifesciences is known for its SAPIEN and SAPIEN 3 transcatheter heart valves.
Strengths:
Extensive experience and a strong track record in the development of TAVR technology.
Continued innovation with a focus on enhancing valve designs and delivery systems.
2. Medtronic plc:
Overview: Medtronic is a global medical technology company that has a significant presence in the TAVR market with its CoreValve and Evolut R transcatheter valves.
Strengths:
Robust product portfolio with a range of TAVR solutions.
Ongoing commitment to research and development, leading to advancements in valve technology.
3. Boston Scientific Corporation:
Overview: Boston Scientific is actively involved in the TAVR market through its LOTUS Edge valve system.
Strengths:
Focus on addressing paravalvular leak issues with its repositionable and retrievable LOTUS valve.
Emphasis on delivering a comprehensive range of structural heart solutions.
4. Abbott Laboratories:
Overview: Abbott, through its Structural Heart division, offers the Portico transcatheter aortic valve system.
Strengths:
Differentiated technology with a self-expanding valve design.
Ongoing clinical trials and research to expand indications and improve outcomes.
5. JenaValve Technology, Inc.:
Overview: JenaValve is known for its JenaValve Pericardial TAVR system.
Strengths:
Unique design with a customizable, self-expanding valve.
Emphasis on patient-specific treatment approaches.
6. Meril Life Sciences Pvt. Ltd.:
Overview: An emerging player in the TAVR market, Meril offers the Myval transcatheter heart valve system.
Strengths:
Focus on affordability and accessibility, especially in emerging markets.
Continued expansion of its product portfolio.
7. Micro Interventional Devices, Inc.:
Overview: Micro Interventional Devices is known for its MIA Technology, including the MIA Transcatheter Annuloplasty Ring System.
Strengths:
Unique focus on annuloplasty solutions for mitral and tricuspid valve repair.
Commitment to addressing structural heart challenges beyond aortic valve replacement.
8. Braile Biomedica:
Overview: Braile Biomedica is a Brazilian company with a presence in the TAVR market through products like the Balloon-Expandable Braile Inovare Valve.
Strengths:
Contribution to the global TAVR market from a regionally based company.
Ongoing efforts in research and development.
9. LivaNova PLC:
Overview: LivaNova, through its Cardiac Surgery division, offers the Perceval Sutureless Aortic Heart Valve.
Strengths:
Sutureless valve design for simplified and faster implantation.
Broad cardiovascular portfolio addressing various cardiac conditions.
Comparative Considerations:
Innovation and Technology: Evaluate the level of innovation in valve design, delivery systems, and associated technologies.
Clinical Evidence: Consider the depth of clinical data and evidence supporting the safety and efficacy of each company's TAVR products.
Global Presence: Assess the global reach and market penetration of each company, including their efforts in both established and emerging markets.
Pipeline and R&D Commitment: Consider the companies' commitment to ongoing research and development, including potential pipeline products and advancements in TAVR technology.
It's crucial to note that the competitive landscape in the TAVR market is dynamic, and new players or developments may have emerged since my last update. Healthcare professionals and industry stakeholders should refer to the latest market reports and company announcements for the most current information.
0 notes
Get to Understand About Myval THV: Transcatheter Heart Valves Online | Meril Life
Discover Myval transcatheter heart valve details, technical specifications, benefits & how it is used in TAVR or TAVI procedure Visit Meril Life today to get the brochure!
https://www.merillife.com/medical-devices/vascular-intervention/heart-valves/TAVR/myval
0 notes